GeneDx Holdings Corp. Revenue Breakdown
No Revenue Breakdown for WGS on this site yet.
- 2025-12-31: Others Not split by product in the filing$427.54M100.00%; Total revenue $427.54M.
- 2024-12-31: Others Not split by product in the filing$305.45M100.00%; Total revenue $305.45M.
- 2023-12-31: Others Not split by product in the filing$202.57M100.00%; Total revenue $202.57M.
- 2022-12-31: Others Not split by product in the filing$234.69M100.00%; Total revenue $234.69M.
Source checked: the stored Revenue Breakdown page for WGS.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $427.54M 100.00% | $427.54M |
| 2024-12-31 | Not split by product in the filing $305.45M 100.00% | $305.45M |
| 2023-12-31 | Not split by product in the filing $202.57M 100.00% | $202.57M |
| 2022-12-31 | Not split by product in the filing $234.69M 100.00% | $234.69M |
| 2021-12-31 | Not split by product in the filing $212.19M 100.00% | $212.19M |
| 2020-12-31 | Not split by product in the filing $179.32M 100.00% | $179.32M |
| 2019-12-31 | Not split by product in the filing $196.17M 100.00% | $196.17M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $114.44M 100.00% | $114.44M |
| 2026-03-31 | Not split by product $102.25M 100.00% | $102.25M |
| 2025-12-31 | Not split by product $120.99M 100.00% | $120.99M |
| 2025-09-30 | Not split by product $116.74M 100.00% | $116.74M |
| 2025-06-30 | Not split by product $102.69M 100.00% | $102.69M |
| 2025-03-31 | Not split by product $87.11M 100.00% | $87.11M |
| 2024-12-31 | Not split by product $95.64M 100.00% | $95.64M |
| 2024-09-30 | Not split by product $76.87M 100.00% | $76.87M |
| 2024-06-30 | Not split by product $70.51M 100.00% | $70.51M |
| 2024-03-31 | Not split by product $62.42M 100.00% | $62.42M |
| 2023-12-31 | Not split by product $57.42M 100.00% | $57.42M |
| 2023-09-30 | Not split by product $53.30M 100.00% | $53.30M |
| 2023-06-30 | Not split by product $48.71M 100.00% | $48.71M |
| 2023-03-31 | Not split by product $43.14M 100.00% | $43.14M |
| 2022-12-31 | Not split by product $61.35M 100.00% | $61.35M |
| 2022-09-30 | Not split by product $83.23M 100.00% | $83.23M |
| 2022-06-30 | Not split by product $36.17M 100.00% | $36.17M |
| 2022-03-31 | Not split by product $53.94M 100.00% | $53.94M |
| 2021-12-31 | Not split by product $57.80M 100.00% | $57.80M |
| 2021-09-30 | Not split by product $43.18M 100.00% | $43.18M |
| 2021-06-30 | Not split by product $47.02M 100.00% | $47.02M |
| 2021-03-31 | Not split by product $64.20M 100.00% | $64.20M |
| 2020-12-31 | Not split by product $63.96M 100.00% | $63.96M |
| 2020-09-30 | Not split by product $38.61M 100.00% | $38.61M |
| 2020-06-30 | Not split by product $30.10M 100.00% | $30.10M |
| 2020-03-31 | Not split by product $46.66M 100.00% | $46.66M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |